ClinicalTrials.gg
RecruitingNCT05766670Updated Oct 14, 2026

Intramedullary Calcium Sulfate Antibiotic Depot

A Phase 3 interventional study of Vancomycin Hydrochloride and Gentamicin in Open tíbia Fracture, Osteomyelitis Tibia and Tibial Fractures, sponsored by Wake Forest University Health Sciences. Recruiting at 12 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Wake Forest University Health Sciences · Phase 3, Interventional, and Other

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.
Updated Oct 14, 2026Enrollment updatedStudy contact changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
242
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 50 studies in Tibial Fractures with a site in United States — 15 open to participants now, 18 under way, 3 of them phase 3. Tibial Fractures · United States.

Planned enrollment
9th of 38
242 · median 53
Started
2024
with 3 others
Phase 3
4 of 50
2 open now
Primary completion
2027-01
later than 8 of 17 live
Registered
41st of 50
by date
Lead sponsor
3 of 50
Wake Forest University Health Sciences

Among the 50 studies in Tibial Fractures with a site in United States, this one is the 9th largest by planned enrollment of the 38 interventional ones that give a count, is one of 4 that started in 2024, is one of 4 in phase 3, reaches primary completion later than 8 of the 17 other live ones, and was the 41st registered.

Tibial Fractures

136 studies on the registry are indexed under Tibial Fractures; 38 are open to participants now.

Browse Tibial Fractures studies →

Open to participants now

15 of the 50 studies in Tibial Fractures with a site in United States are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 27 Tibial Fractures studies recruiting now, 13 (48%) set no upper age limit and 7 (26%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Tibial Fractures with a site in United States, or all of them as a file.
02

Study summary

The goal of this randomized clinical trial is to study the best treatment for open lower leg fractures to prevent infection. The main questions it aims to answer is if treating tibia fracture patients with a calcium sulfate antibiotic depot is better at preventing infection that the standard of care.

Read the detailed description

This research is a randomized clinical trial aimed to reduce the frequency of fracture related infections following open tibia fracture. The proposed test methods for infection reduction is use of an antibiotic depot placed inside the bone at the time of final fracture treatment. This is in addition to standard of care wound care, fracture fixation with intramedullary nailing, and peri-operative systemic antibiotics.

This prospective randomized clinical trial will compare outcomes between patients treated with an antibiotic depot placed inside the bone at the time of final fracture fixation and those treated with traditional standard of care intramedullary nailing.

The target population for the proposed study is patients with severe open tibia fractures (Type II or III) who require definitive fixation with intramedullary nail recruited form one of the participating sites during the index hospitalization.

One group will be treated prophylactically suing a calcium sulfate antibiotic depot at the time of definitive fixation, while the second group will be treated with a standard of care intramedullary nail without the antibiotic depot.

Participants will be followed for 12 months (data capture includes patient interviews and clinical data capture from the treatment team and medical record at baseline, 6 weeks, 3 months, 6 months, and 12 months).

03

Conditions studied

  • Open tíbia Fracture
  • Osteomyelitis Tibia
  • Tibial Fractures

Browse trials for

Keywords

  • antibiotic depot
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients 18 years and older
  • Type II or III open tibia fracture requiring definitive fixation with intramedullary nail

Exclusion criteria

Exclusion Criteria:

  • Less than 18 years of age
  • Allergy to vancomycin or tobramycin
  • Hypercalcemia
  • Unable to speak English or Spanish
  • No email, phone, or other point of contact
  • Pregnant and lactating women
  • Prisoner
05

Study design

Phase
Phase 3
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
242 participants (estimated)

Study arms

  • Other
    Intramedullary calcium sulfate antibiotic depot prior to Intramedullary nailing (IMN) placement (CS)

    The intramedullary calcium sulfate antibiotic depot will be mixed sterilely to include at minimum 20cc calcium sulfate powder mixed with 1g of vancomycin powder and 1.2g of tobramycin powder per 10cc of calcium sulfate.

    Drug: Vancomycin Hydrochloride · Drug: Gentamicin

  • Other
    Standard of care intramedullary nail (SN)

    Standard of care intramedullary nail

    Other: Standard Intramedullary Nail

Interventions

  • DrugVancomycinStudies of VancomycinVancomycin pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    The intramedullary calcium sulfate antibiotic depot will be mixed sterilely to include at minimum 20cc calcium sulfate powder mixed with 1g of vancomycin powder and 1.2g of tobramycin powder per 10cc of calcium sulfate.

    Also known as: antibacterial prescription medicine

  • DrugGentamicinsStudies of GentamicinsGentamicins pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    The intramedullary calcium sulfate antibiotic depot will be mixed sterilely to include at minimum 20cc calcium sulfate powder mixed with 1g of vancomycin powder and 1.2g of tobramycin powder per 10cc of calcium sulfate.

    Also known as: injection is used to treat certain serious infections that are caused by bacteria such as meningitis

  • OtherStandard Intramedullary Nail

    Standard Intramedullary Nail

    Also known as: metal rod that is inserted into the medullary cavity of a bone and across the fracture in order to provide a solid support for the fractured bone

06

What researchers measure

Primary outcomes

  1. Number of participants who develop deep surgical site infection (SSI)

    Number of participants in each group who develop surgical site infection (SSI) as defined by the criteria establish by the Centers for Disease Control and Prevention (CDC). The CDC criteria define deep as occurring within 30 or 90 days after the procedure. However, we will continue to follow patients for 12 months and document any infections and other complications during this period.

    Time frame: Month 12

Secondary outcomes

  1. Number of Participants who Return to the Operating Room (OR)

    Number of Participants who Return to the Operating Room (OR)

    Time frame: Month 12

  2. Percentage of Union

    Union is the gradual process of bone regeneration after a fracture. Percentage of Union, as determined by the treating surgeon, will be assessed via radiographs. Recorded by surgeon as yes/no answers.

    Time frame: week 6, month 3, month 6 and month 12

  3. Time to Union

    Captured in days

    Time frame: week 6, month 3, month 6 and month 12

  4. Radiographic Union Scale in Tibial fractures (RUST) score

    The RUST score ranges from a minimum score of 4 (definitely not healed) to a maximum score of 12 (completely healed). The final x-ray obtained within a 12-month period following injury will be uploaded to REDCap for review by a blinded panel of investigators from participating sites.

    Time frame: week 6, month 3, month 6, and month 12

  5. Presence of drainage from incision and wounds

    When present, patients will be asked to document the duration of drainage. Duration will be treated as a continuous variable with 7 days of drainage categorized as "persistent drainage".

    Time frame: week 6, month 3, month 6 and month 12

  6. Average Time to Return to Work/Duty

    number of days

    Time frame: week 6, month 3, month 6 and month 12

  7. International Physical Activity Questionnaire (IPAQ)

    IPAQ measures the total amount of physical activity completed in a 7 day period by calculating the minutes per week in in each physical activity level domain (walking, moderate and vigorous) by a metabolic equivalent energy (MET) expenditure estimate. Walking = 3.3 x number of walking minutes x number of walking days Moderate activity= 4.0 x number activity minutes x number of days Vigorous activity = 8 x number of activity minutes x number of days Total = Walking MET-min/wk+moderate MET-min/wk+vigorous MET-min/wk

    Time frame: Baseline, 3 month, 6 month, 12 month

  8. PROMIS-29 Subscale--Physical Function

    The PROMIS-29 scales will be scored using a T-score metric method. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. The sum of the PROMIS results in the raw score, which lies between 4 and 20 - Higher scores means higher physical function; lower scores represent lower physical function

    Time frame: week 6, month 3, month 6 and month12

  9. PROMIS-29 Subscale--Physical Function: Anxiety

    The PROMIS-29 scales will be scored using a T-score metric method. The PROMIS Anxiety item banks assess self-reported fear (fearfulness, panic), anxious misery (worry, dread), hyperarousal (tension, nervousness, restlessness), and somatic symptoms related to arousal (racing heart, dizziness). A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of anxiety; lower scores represent lower level of anxiety

    Time frame: week 6, month 3, month 6 and month12

  10. PROMIS-29 Subscale--Depression

    The PROMIS-29 scales will be scored using a T-score metric method. For each scale, respondents are asked how often in the past 7 days they have experienced specific depression symptoms, using a 5-point ordinal rating scale of "Never," "Rarely," "Sometimes," "Often," and "Always." A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of depression; lower scores represent lower level of depression

    Time frame: week 6, month 3, month 6 and month12

  11. PROMIS-29 Subscale--Fatigue

    The PROMIS-29 scales will be scored using a T-score metric method. A higher PROMIS T-score represents more of the concept being measured. For negatively-worded concepts like fatigue, a T-score of 60 is one SD worse than average. By comparison, a fatigue T-score of 40 is one Standard Deviation better than average. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of fatigue. Mean fatigue scores in the four study samples ranged from 18.5 to 22.8 on the PROMIS (PROMIS) Fatigue-Short Form (F-SF) (potential range 7-35); from 14.8 to 47.8 on the MFSI-SF (potential range 24-86); and from 3.6 to 6.6 on the BFI (potential range 0-10).

    Time frame: week 6, month 3, month 6 and month12

  12. PROMIS-29 Subscale--Sleep Disturbance

    The PROMIS-29 scales will be scored using a T-score metric method. The PROMIS Sleep Disturbance instruments assess self-reported perceptions of sleep quality, sleep depth, and restoration associated with sleep. This includes perceived difficulties and concerns with getting to sleep or staying asleep, as well as perceptions of the adequacy of and satisfaction with sleep. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of sleep disturbance. Total score is the sum of the seven subscale scores (ie, quality of sleep, quantity of sleep, sleep onset latency, midsleep awakenings, early awakenings, medications for sleep, excessive daytime sleepiness) that can range from 0 (no disturbance) to 147 (extreme sleep disturbance).

    Time frame: week 6, month 3, month 6 and month12

  13. PROMIS-29 Subscale--Pain Interference

    The PROMIS-29 scales will be scored using a T-score metric method. PROMIS Pain Intensity T-scores from 20-55 are considered within normal limits, 55-60 is mild, 60-70 is moderate, and 70+ is severe. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of pain interference. PROMIS Pain Interference (PROMIS-PI) scale measures the extent to which pain hinders an individual's engagement with physical, mental, cognitive, emotional, recreational, and social activities.

    Time frame: week 6, month 3, month 6 and month12

  14. PROMIS-29 Subscale--Ability to Participate in Social Roles and Activities

    The PROMIS-29 scales will be scored using a T-score metric method. Social function is defined by PROMIS as involvement in, and satisfaction with, one's usual social roles in life's situations and activities. These roles may exist in marital relationships, parental responsibilities, work responsibilities and social activities. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher ability to participate in social roles and activities.

    Time frame: week 6, month 3, month 6 and month12

  15. Veterans RAND 12 Item Health Survey (VR-12) Domain --General Health

    The VR-12 is a measure of global health that correspond to seven domains. Together, these items are summarized into a Physical Component Score and a Mental Component Score. The VR-12 is a patient-reported instrument from which physical and mental health component summary scores (PCS and MCS) are derived. The PCS and MCS are normalized using TScore and are on a 0-100 scale. The interpretation is based on a population mean of 50 and standard deviation of 10. Higher scores represent a better outcome. The VR-12 items assess physical functioning, role limitations due to physical or mental health problems, pain, energy, mental health, social functioning, and general health.

    Time frame: week 6, month 3, month 6 and month12

  16. Veterans RAND 12 Item Health Survey (VR-12) Domain--Physical Functioning

    The VR-12 is a measure of global health that correspond to seven domains. Together, these items are summarized into a Physical Component Score and a Mental Component Score. The VR-12 is a patient-reported instrument from which physical and mental health component summary scores (PCS and MCS) are derived. The PCS and MCS are normalized using TScore and are on a 0-100 scale. The interpretation is based on a population mean of 50 and standard deviation of 10. Higher scores represent a better outcome. The VR-12 items assess physical functioning, role limitations due to physical or mental health problems, pain, energy, mental health, social functioning, and general health.

    Time frame: week 6, month 3, month 6 and month12

  17. Veterans RAND 12 Item Health Survey (VR-12) Domain--Role Limitations

    The VR-12 is a measure of global health that correspond to seven domains. Together, these items are summarized into a Physical Component Score and a Mental Component Score. The PCS and MCS are normalized using TScore and are on a 0-100 scale. The interpretation is based on a population mean of 50 and standard deviation of 10. Higher scores represent a better outcome.

    Time frame: week 6, month 3, month 6 and month12

  18. Veterans RAND 12 Item Health Survey (VR-12) Domain--Pain

    The VR-12 is a measure of global health that correspond to seven domains. Together, these items are summarized into a Physical Component Score and a Mental Component Score. The PCS and MCS are normalized using TScore and are on a 0-100 scale. The interpretation is based on a population mean of 50 and standard deviation of 10. Higher scores represent a better outcome.

    Time frame: week 6, month 3, month 6 and month12

  19. Veterans RAND 12 Item Health Survey (VR-12) Domain--Fatigue

    The VR-12 is a measure of global health that correspond to seven domains. Together, these items are summarized into a Physical Component Score and a Mental Component Score. The PCS and MCS are normalized using TScore and are on a 0-100 scale. The interpretation is based on a population mean of 50 and standard deviation of 10. Higher scores represent a better outcome.

    Time frame: week 6, month 3, month 6 and month12

  20. Veterans Rand 12 Item Health Survey (VR-12) Domain --Social Functioning

    The VR-12 is a measure of global health that correspond to seven domains. Together, these items are summarized into a Physical Component Score and a Mental Component Score. The PCS and MCS are normalized using TScore and are on a 0-100 scale. The interpretation is based on a population mean of 50 and standard deviation of 10. Higher scores represent a better outcome.

    Time frame: week 6, month 3, month 6 and month12

  21. Veterans Rand 12 Item Health Survey (VR-12) Domain--Mental Health

    The VR-12 is a measure of global health that correspond to seven domains. Together, these items are summarized into a Physical Component Score and a Mental Component Score. The PCS and MCS are normalized using TScore and are on a 0-100 scale. The interpretation is based on a population mean of 50 and standard deviation of 10. Higher scores represent a better outcome.

    Time frame: week 6, month 3, month 6 and month12

07

Study locations

11 of 12 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2024 (actual). Primary completion is estimated for Jan 2027, 33 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2023
First posted
Mar 13, 2023
StartActual
Apr 8, 2024
Primary completionEst.
Jan 2027
CompletionEst.
Jan 2028
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
2 sites added
Show 2 added (2 United States)
  • University of Chicago · Chicago, United States
  • Carilion Clinic · Roanoke, United States
Oct 14, 2026
Enrollment
497→242
Oct 14, 2026
Contact
Study contact's phone or email changed: c•••@atriumhealth.org→c•••@advocatehealth.org; r•••@atriumhealth.org→R•••@advocatehealth.org. See the current contact
Oct 14, 2026
Site contacts
Changed at 3 sites. See the sites
Show 3 sites
  • Atrium Health Carolinas Medical Center · Charlotte, United StatesContact c•••@atriumhealth.org→C•••@advocatehealth.org
  • Atrium Health Cabarrus · Concord, United StatesContact e•••@atriumhealth.org→E•••@advocatehealth.org
  • Atrium Health Wake Forest Baptist Medical Center · Winston-Salem, United StatesContact c•••@atriumhealth.org→C•••@advocatehealth.org
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    2 sites added
    Show 2 added (2 United States)
    • University of Chicago · Chicago, United States
    • Carilion Clinic · Roanoke, United States
    Enrollment 497→242
    Contact Study contact's phone or email changed: c•••@atriumhealth.org→c•••@advocatehealth.org; r•••@atriumhealth.org→R•••@advocatehealth.org. See the current contact
    Site contacts Changed at 3 sites. See the sites
    Show 3 sites
    • Atrium Health Carolinas Medical Center · Charlotte, United StatesContact c•••@atriumhealth.org→C•••@advocatehealth.org
    • Atrium Health Cabarrus · Concord, United StatesContact e•••@atriumhealth.org→E•••@advocatehealth.org
    • Atrium Health Wake Forest Baptist Medical Center · Winston-Salem, United StatesContact c•••@atriumhealth.org→C•••@advocatehealth.org
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05766670
Responsible party
Sponsor
First posted
Mar 13, 2023
Start date
Apr 8, 2024
Primary completion
Jan 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Oct 14, 2026

Study contacts

Christine Churchill, MA
Contact
christine.churchill@advocatehealth.org
7043552000
Rachel B Seymour, PhD
Contact
Rachel.Seymour@advocatehealth.org
7043552000
Rachel B Seymour, PhD
principal investigator · Wake Forest University Health Sciences
Jessica Rivera, MD
principal investigator · Louisiana State University Health Science Center

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Vancomycin · Gentamicins

Start the discussion